Advent to invest $175-M for minority stake in animal pharma player Felix
Private Equity firm Advent International (led by its India unit) is to invest USD 175 million for a minority stake in Felix Pharmaceuticals ,Gurugram-and Dublin Ireland-based animal pharma player. The deal had both primary and secondary componentsGuggenheim Securities were financial advisors for Advent and Lincoln International were the financial advisors for Felix. JSA, Aurthur Cox and A&L Goodbody were the legal advisors on the transaction.Co-founded in 2015 by Neeraj Agrawal, Felix Pharma is a manufacturer of off-patent medicines for “companion animals”. It has two manufacturing facilities in Madhya Pradesh and a research and development centre in Uttar Pradesh.
Want to receive such news items in your inbox? Click Here to sign up for a trial.